Powered by RND
PodcastsBusinessAUTM on the Air

AUTM on the Air

AUTM
AUTM on the Air
Latest episode

Available Episodes

5 of 278
  • Innovation Needs Connection: Finding the Human Side of Tech Transfer with Joe Runge
    It’s often the connections between people that keep innovation burning bright. My guest today is Joe Runge. He’s spent more than two decades exploring that truth from several angles, including as a practicing patent lawyer, published scientist, educator, and veteran of the innovation economy. Joe holds the rare distinction of being the only student in history to earn both a law degree and a master’s degree in biology simultaneously from the University of Iowa, a combination that uniquely shaped his perspective on how science and law intersect to move discoveries into the world.Today, Joe serves as Associate Director and Co-Founder of the UNeTech Institute, a joint research institute between the University of Nebraska Omaha and the University of Nebraska Medical Center. His work extends far beyond traditional tech transfer. He’s helped secure over $5 million in competitive funding through economic development and entrepreneurship grants, while guiding faculty, startups, and community partners through the often-uncertain process of turning research into real-world impact.In our conversation, Joe reflects on his recent TEDx Omaha talk, "Innovation Needs Connection," in which he explores how a single word can change everything and why understanding your audience is just as critical as understanding your invention. We talk about the emotional side of tech transfer, from frustration and failure to purpose and gratitude. We also discuss how UNeTech’s latest ventures, including Respira AI and IMPOWER HEALTH demonstrate what happens when collaboration meets creativity.In This Episode:[01:57] Joe reflects on co-founding UNeTech and the transition from Unimed to a broader vision for innovation in Nebraska.[03:26] Revisiting Joe’s past podcast, Innovation Overground, and how scaling UNeTech changed his focus.[04:15] The origin of Joe’s TEDx Omaha tal,k Innovation Needs Connection, and how one word, stent versus balloon, shifted everything.[07:07] Lessons from the “stent to balloon” moment about language, audience, and empathy in tech transfer.[08:54] Understanding cultural differences between scientists and industry partners.[09:29] Why Joe chose to be open about frustration and anger in his TEDx talk and what that revealed about connection and authenticity.[12:18] Helping inventors stay hopeful despite statistics showing most patents and startups fail.[13:32] How UNeTech reframed innovation work toward workforce development and long-term community impact.[16:02] Balancing urgency and burnout while tackling global challenges like climate change and pandemics.[18:59] The personal reflections and family conversations sparked by Joe’s TEDx experience.[21:30] How applying for TEDx became an unexpected journey of self-discovery and professional identity.[24:58] The meaning behind “big ideas must die three deaths” and learning to value failure as part of excellence.[27:52] Joe’s biggest lessons from projects that didn’t make it to market and how humility plays a role in resilience.[30:21] UNeTech’s exciting startup portfolio, including Respira AI for COPD monitoring and IMPOWER HEALTH’S self-pacing treadmill.[33:23] Joe’s new role with Gearhart Law and how his tech transfer background informs his IP work.[36:27] Emotional intelligence and vulnerability as tools for better collaboration in tech transfer.[38:04] Encouragement to reflect, redefine success, and find personal purpose in innovation work.[39:08] What keeps Joe inspired about the future of innovation and why human connection remains at the heart of progress.Resources: AUTMUNeTech InstituteInnovation needs connection | Joe Runge | TEDxOmahaInnovation Overground PodcastJoe Runge - LinkedInGearhart Law
    --------  
    42:46
  • Accelerating Startups with Michael Lyon
    Some people talk about innovation. Others live it. Michael Lyon has built a career that bridges worlds most of us only dream about, from helping launch the first space tourists to diving miles beneath the ocean surface, and now mentoring the next generation of tech entrepreneurs. A Harvard Law graduate with experience spanning government, finance, and frontier industries, Michael has spent over 40 years helping bold ideas find their place in the real world. Today, he serves as a longtime mentor at the Creative Destruction Lab, guiding hundreds of founders in fields like space, ocean technology, and AI.In this conversation, Michael shares the hard-won lessons behind his new book, Accelerating Startups: Lessons from Mentors. He opens up about the questions founders don’t always stop to ask, like whether they’re truly ready for the risks, trade-offs, and constant pressure that come with building something new. Michael explains why it’s smarter to chase a real-world problem than to fall in love with a piece of technology, and how founders can stay grounded when money, time, and people all pull in different directions. What stands out is how he draws on the precision of a lawyer and the curiosity of an adventurer to illustrate the messy and rewarding nature of the startup path.We also discuss the human side of Tech Transfer, including how universities can better prepare innovators for the leap into business, what it means to listen to mentors truly, and why staying humble often opens more doors than any credential ever could. When the topic turns to AI, Michael keeps it practical, discussing where it helps, where it falls short, and how founders can utilize it without compromising their creative edge. His stories have a lived-in quality that makes you believe progress is built through patience, self-awareness, and the kind of mentorship that keeps you moving when things get hard.In This Episode:[02:15] How Michael helped launch the first space tourists and later mentored hundreds of ventures at the Creative Destruction Lab.[03:40] What inspired him to write Accelerating Startups: Lessons from Mentors, and how common startup challenges led to the book.[05:08] The “Section Zero” question and why founders should pause to ask if they’re truly ready to build a company.[06:45] The personal and professional sacrifices that come with startup life and how timing matters.[08:20] Why reflection, self-awareness, and resilience are critical traits for any founder.[09:30] The trap of “a solution looking for a problem” and how tech transfer teams can help avoid it.[10:45] Why falling in love with the problem, not the technology, is key to real market traction.[11:55] The role of early business plans in aligning co-founders and clarifying assumptions.[12:40] Customer discovery tips for academic founders and how to measure perceived customer value.[14:00] Blind spots Michael often sees in university-based startups and why being coachable changes everything.[15:28] The balance between technology development and commercialization within research spinouts.[16:45] How mastering a 30-second pitch can transform a founder’s understanding of their own business.[18:10] Why many companies struggle with active listening and how coachability affects mentor relationships.[20:25] Building the right founding team and why compatibility and trust matter more than equity splits.[22:30] Michael’s advice on founder “prenups,” equity vesting, and handling co-founder departures.[24:10] How startups should approach global markets early and the role tech transfer offices play in preparing them.[26:30] Inside the Creative Destruction Lab model—goal setting, mentorship quality, and science-based acceleration.[28:20] Legal pitfalls academic entrepreneurs often overlook and why strong agreements matter.[29:45] Michael’s take on AI in startups and how it can streamline, and where human creativity still leads.[31:20] His top three takeaways for new founders include building a business plan, refining your pitch, and staying open to learning.[33:00] Reflections on mentorship, trust, and the patient, disciplined path from idea to impact.Resources: AUTMAccelerating Startups: Lessons From MentorsMichael Lyon - [email protected] Destruction Lab
    --------  
    34:11
  • Driving Vision Forward: Inside the Foundation Fighting Blindness with CEO Jason Menzo
    Fighting blindness requires science, strategy, and a great deal of heart. Today’s guest is Jason Menzo, CEO of the Foundation Fighting Blindness, the world’s largest private funder of retinal disease research. Since assuming the role in 2022, after serving as President and COO, Jason has helped raise nearly a billion dollars and is backing over 100 projects across 86 labs and clinical centers worldwide. With more than two decades in ophthalmology at Sun Ophthalmologics, Nycox SA, Bausch & Lomb, and Bayer, he brings sharp business instincts and a deep commitment to restoring sight.Before joining the Foundation, Jason co-founded and led several eye-care ventures focused on bringing breakthrough treatments to patients more quickly. That for-profit experience now fuels mission-driven innovation, new funding models, and partnerships that move discoveries from the lab to the clinic. A standout example is the early Foundation support for the research behind Luxturna, the first FDA-approved gene therapy for an inherited disease, demonstrating how bold, risk-tolerant philanthropy can transform medicine when academia, government, and industry collaborate.A hallmark of his leadership is the R&D Fund, a $160 million venture philanthropy model with an eight-to-one leverage ratio. This bridges academic research and commercialization, drawing in private capital to advance promising therapies. He has also championed a global network of over 40 clinical centers in 10 countries and strengthened the talent pipeline through fellowships and translational awards. Today, 88% of retinal treatments in clinical trials can be traced back to Foundation-funded programs.Today, we discuss where science, policy, and philanthropy converge to bring sight-saving treatments closer to reality. We discuss the proposed Venture Philanthropy Enhancement Act and look ahead to gene-agnostic therapies, cell regeneration, and whole-eye transplant initiatives with ARPA-H. In This Episode:[01:30] Jason reflects on his transition from the pharmaceutical world to nonprofit work and what drew him to the Foundation.[03:10] Discussion of Luxturna’s groundbreaking FDA approval and how early Foundation funding contributed to its success.[05:30] Jason explains how the Foundation balances basic and translational research to accelerate cures for retinal diseases.[07:45] Overview of the Foundation’s five-year strategic plan and its flexible approach to adapting research priorities.[09:15] Insight into the importance of collaboration among universities, the NIH, and industry partners to move discoveries into the clinic.[11:00] Jason highlights the creation and purpose of the R&D Fund, a venture philanthropy model launched in 2018.[13:00] The Fund’s success in achieving an 8-to-1 leverage ratio and attracting top venture capital partners.[15:10] How the Foundation conducts due diligence when selecting companies for investment.[17:30] Explanation of how the R&D Fund differs from traditional research grants and why selectivity is key.[19:00] Jason introduces the Venture Philanthropy Enhancement Act and discusses its potential impact on funding for rare diseases.[22:00] Story of a near-failed company that survived through philanthropic support and produced life-changing clinical trial results.[24:00] The Foundation’s suite of grants and awards supporting early-career and translational researchers.[26:10] Career Development Awards and their role in retaining top talent in retinal disease research.[28:00] How the Foundation partners with tech transfer offices to bridge the “Valley of Death” between discovery and commercialization.[30:00] Metrics beyond publications—how FFB measures its real-world impact on treatments and cures.[32:15] Jason shares the emerging technologies he finds most promising, including gene-agnostic and cell-based therapies.[34:10] Discussion on the global prevalence of blindness and the Foundation’s efforts to prioritize late-stage and restorative therapies.[36:00] Jason outlines upcoming funding opportunities and deadlines for university researchers.[37:30] Final reflections on hope, awareness, and collaboration shaping the future of vision restoration.Resources: AUTMJason Menzo - Foundation Fighting BlindnessJason Menzo - LinkedInJason Menzo - X
    --------  
    48:09
  • From Ideas to Impact: Kentucky’s Statewide Commercialization Approach with Kayla Meisner
    Not every university has the resources to build and maintain a Tech Transfer office, and for many smaller institutions, that has long meant sitting on the sidelines. In Kentucky, leaders decided to try something different. Instead of each campus building its own program from scratch, they pooled efforts into a single statewide network. That collaboration became Kentucky Commercialization Ventures, or KCV, a model that’s now showing what inclusive innovation can look like in practice.At the center of this work is Kayla Meisner, Executive Director of KCV, who has guided the initiative from an early concept into a growing program with national attention. Since its launch in 2020, KCV has more than tripled its funding, doubled its staff, and helped innovators at all levels find clear pathways into commercialization. By combining proof-of-concept funding with hands-on coaching and shared services, the team has turned early ideas into intellectual property, startups, and partnerships that feed back into Kentucky’s economy.In this episode, Kayla explains what it takes to build trust across institutions, how programs like the Innovation Fellowship and KCV Invent are preparing the next generation of talent, and why partnerships outside of academia are strengthening the state’s innovation ecosystem. She also reflects on what other regions can learn from Kentucky’s experience, from getting state economic leaders on board to setting up governance that keeps everyone invested in long-term success.In This Episode:[03:18] Kayla shares the origins of KCV and how it fits within the Kentucky Science and Technology Corporation’s 40-year mission.[05:24] She explains how state dollars are invested into proof-of-concept funding and stipends to support innovators.[06:30] Kayla describes the challenges Kentucky faced as an EPSCoR and NIH IDeA state and why collective action was needed.[09:37] She outlines the gap analysis that showed most partner schools lacked IP policies and full-time tech transfer staff.[12:15] The discussion turns to how KCV scaled its services while running on less than $1 million a year in the early days.[15:30] Kayla highlights the importance of coaching and mentorship in turning early-stage disclosures into IP.[17:40] The story of Dr. Rachel Tinius at Western Kentucky University illustrates how small investments can lead to major commercialization success.[18:26] Kayla talks about the KCV Innovation Fellowship and how it prepares students and faculty for entrepreneurship.[22:06] She explains how the fellowship has grown into a semester-based, cohort model that builds practical commercialization skills.[24:11] The conversation shifts to Kentucky’s six regional innovation hubs and their statewide economic impact.[29:01] Kayla details how KCV now requires assessments before opt-in, creating clearer pathways and buy-in for institutions and innovators.[32:37] The IMPACT competition is discussed, with KCV celebrating its first-ever community and technical college winner.[35:17] Kayla addresses the $8.25 million NSF EDGE award and the systemic barriers it is helping to solve at smaller institutions.[46:28] She reflects on the challenge of securing sustainable funding and the importance of demonstrating ROI.[49:57] Kayla highlights ecosystem partnerships with groups like the Kentucky Bar Association, USPTO, and Kentucky Distillers Association.[54:30] The conversation explores talent development through internships and the launch of KCV Invent, funded by the NSF Excellence Program.[56:43] Kayla offers three recommendations for other states interested in replicating the KCV model: build state relationships, conduct gap analyses, and establish governance.[59:45] She reflects on what has surprised her most about the centralized approach and why it has proven so effective.Resources: AUTMKayla Meisner - Kentucky Commercialization VenturesKayla Meisner - LinkedInKentucky Science & Technology CorporationDr. Rachel Tinius, Ph.D., EP-CBumptUp LabsUSPTO – Midwest Regional Office
    --------  
    1:06:17
  • The Price of Patents: How New Tax Proposals Could Transform IP Strategy with Erin Daly
    A proposed shift in U.S. patent policy is sparking debate about the future of intellectual property. The idea on the table is a value-based tax that would replace, or sit on top of, the USPTO’s traditional flat-fee system. Instead of paying predictable maintenance fees, patent owners could face annual charges tied to the assessed value of their inventions. This move would dramatically change how portfolios are managed and funded.To walk us through the implications, we’re joined by Erin M. Daly, Ph.D., Esq., founder of Daly Law & Strategy. Erin started out in organic chemistry before moving into patent law, and she’s spent her career working with biotech companies and universities on everything from early-stage research to clinical programs. That combination of lab background and legal know-how gives her a practical view of how changes in patent policy land on the ground.We discuss why putting a dollar value on patents is never straightforward and how a tax like this could create big headaches for industries that depend on large portfolios, like biotech, semiconductors, and emerging green technologies. We also look at what startups and universities might face if they’re hit with new costs long before their patents generate any revenue. In This Episode:[01:57] The proposed value-based patent tax is outlined and contrasted with current USPTO fees.[02:50] Erin explains how the new system would resemble a property tax on intellectual property.[03:49] The U.S. has historically treated patents as a right supported by fees, not as taxable assets.[04:42] The proposal is still at the idea stage with no formal rule or bill introduced.[06:08] Patent valuation challenges are described, including subjectivity and lack of comparables.[08:07] Legal questions emerge about USPTO authority, due process, and potential litigation.[10:44] Erin outlines compliance concerns, audits, and paperwork burdens if the IRS were involved.[12:49] Biotech and pharma are identified as sectors most at risk under a value-based tax.[13:45] Semiconductor and AI industries could face massive valuation tracking costs.[14:40] Green tech companies may abandon patents if taxed before commercialization.[15:59] Strategic steps for tech transfer offices and companies to assess exposure are discussed.[17:39] Trade secrets may become more appealing as an alternative to patents in some cases.[18:24] Companies might restructure portfolios or shift filings internationally to reduce risk.[20:45] Erin emphasizes the importance of monitoring Congress, Federal Register updates, and IRS guidance.[22:55] Coalition groups and bar associations begin mobilizing to oppose the tax proposal.[23:33] Early legal challenges are expected to test the limits of USPTO authority and valuation disputes.[25:26] We close with a reminder that patent costs are under increasing scrutiny.Resources: AUTMDaly Law & StrategyErin M. Daly, Ph.D. - LinkedInDaly Law & Strategy - FacebookUSPTO (United States Patent and Trademark Office)Federal RegisterBIO (Biotechnology Innovation Organization)Intellectual Property Owners Association (IPO)
    --------  
    26:05

More Business podcasts

About AUTM on the Air

AUTM on the AIR is the weekly podcast that brings you conversations about the impact of research commercialization and the people who make it happen. Join us for interviews with patent and licensing professionals, innovators, entrepreneurs, and tech transfer leaders on the issues and trends that matter most.  
Podcast website

Listen to AUTM on the Air, Take on Tomorrow and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v7.23.11 | © 2007-2025 radio.de GmbH
Generated: 11/4/2025 - 7:26:19 PM